Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (GB:0O59)
LSE:0O59
0O59 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€77.73 - €106.14
Previous CloseN/A
Volume934.71K
Average Volume (3M)780.33K
Market Cap
$125.69B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)29.8
Beta0.49
Next Earnings
Jan 30, 2025EPS Estimate
1.41Last Dividend Ex-Date
May 13, 2024Dividend Yield3.75%
Share Statistics
EPS (TTM)3.37
Shares Outstanding1,263,122,700
10 Day Avg. Volume557,691
30 Day Avg. Volume780,333
Standard Deviation0.06
R-Squared0.20
Alpha0.00398
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€114.27Price Target Upside9.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceSanofi's fiscal year 2024 results and fiscal year 2025 guidance set the stock up well for 2025, with expectations of consistent earnings per share beat and raise.
Growth PotentialThe strong pipeline, including four important catalysts expected, positions the company for potential blockbuster launches.
Investment AttractivenessThe low price-to-earnings ratio makes the stock attractive for investment.
Bears Say
Conservative Price ObjectiveThe unchanged price objective of 122 EUR is considered conservative given Sanofi's double-digit EPS growth rates.
Dilution ConcernsA greater amount of stock repurchase or accretive M&A could offset Opella-related dilution.
Market VolatilityThere could be stock volatility when SAN reports results on January 30.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
13.12% Mutual Funds
<0.01% Other Institutional Investors
72.50% Public Companies and
Individual Investors
0O59 FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest share price was €77.73 and its highest was €106.14 in the past 12 months.
What is Sanofi’s market cap?
Sanofi’s market cap is $125.69B.
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jan 30, 2025 which is 7 days ago.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Jan 30, 2025. The company reported €1.31 earnings per share for the quarter, missing the consensus estimate of €1.353 by -€0.043.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of €3.759 which represents an annual dividend yield of 3.75%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is 1.41.
How many shares outstanding does Sanofi have?
Sanofi has 1,263,122,700 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of €1.31 in its last earnings report, missing expectations of €1.353. Following the earnings report the stock price went up 1.252%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in GB:0O59
---
Company Description
Sanofi
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
---
0O59 Company Deck
---
0O59 Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, driven by strong sales growth, successful product launches, and significant R&D advancements. Despite some challenges like gross margin pressure and increased expenses, the company's strategic focus on innovation and market expansion supports a strong outlook.Read More>---
0O59 Stock 12 Month Forecast
Average Price Target
€114.27
▲(9.45% Upside)
Technical Analysis
Best Analysts Covering 0O59
1 Year
1 Year Success Rate
18/22 ratings generated profit
1 Year Average Return
+5.44%
reiterated a buy rating 6 days ago
Copying Graham Parry's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +5.44% per trade.
---